Cite

    Timmis, K. et al. (n.d.). Synthetic consortia of nanobody‐coupled and formatted bacteria for prophylaxis and therapy interventions targeting microbiome dysbiosis‐associated diseases and co‐morbidities. Microbial biotechnology. 12 (1), pp. 58-65. [Online].